12:00 AM
Dec 17, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Helsinn, Otsuka Holdings sales and marketing update

Helsinn said Otsuka's Taiho Pharmaceutical Co. Ltd. subsidiary launched a 0.75 mg infusion bag formulation of Aloxi...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >